Methylnaltrexone and rifaximin treatments significantly improve chronic “leaky gut” in a diet-induced mouse model of non-alcoholic fatty liver disease
Year: 2020
Type: article
Source: Journal of Hepatology
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4233189003
